|
Nov 2
|
Amarin Corporation plc (NASDAQ:AMRN) Q3 2023 Earnings Call Transcript
|
|
Aug 9
|
Amarin Provides Pricing & Reimbursement Updates for VAZKEPA (icosapent ethyl) in The Netherlands and Italy
|
|
Aug 8
|
Amarin And Neopharm Announce Exclusive Commercialization Agreement for VAZKEPA® (Icosapent Ethyl) in Israel
|
|
Jul 5
|
Amarin (NASDAQ:AMRN) shareholders have endured a 83% loss from investing in the stock three years ago
|